HMGA2 and liposarcoma: Unlike the preponderance of studies performed on benign mesenchymal tumors, only a few preliminary studies have determined the role of HMGA2 misexpression in malignant mesenchymal tumors such as well differentiated liposarcomas and osteosarcomas [37,60,76,91].